Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#PostpartumCare

Home » #PostpartumCare
AASLD 2023 | Professor Zhihua Liu’s Team: Revealing the Dynamic Changes in T-Cell Immunity during Pregnancy and Postpartum Period in Women with Chronic HBV Infection and Its Relationship with Infection Status

AASLD 2023 | Professor Zhihua Liu’s Team: Revealing the Dynamic Changes in T-Cell Immunity during Pregnancy and Postpartum Period in Women with Chronic HBV Infection and Its Relationship with Infection Status

Posted by By Mourabit Halima 2024.01.14
Editor's Note: The 2023 American Association for the Study of Liver Diseases (AASLD) Annual Meeting has recently concluded in Boston, USA. A study in the field of immunology related to hepatitis…
Read More
Recent Posts
  • Moving from Relapsed/Refractory to Early Treatment: Professor Cyrille Touzeau Interprets the EMN34 Study, Elranatamab Opens a New Chapter in Precision Intervention for HR SMM
  • Breaking the Deadlock with “Synthetic Lethality” Targeting MTAP Deficiency: AZD3470 Achieves 58% ORR in Multi-line Drug-Resistant Hodgkin Lymphoma
  • Shifting from Passive to Proactive: Final PFS2 Data from the SERENA-6 Study Released; Camizestrant Switch Therapy Significantly Extends Survival Benefits for ESR1-Mutant Patients
  • 25% Risk Reduction and First-line Intensification: frontMIND Study Opens a New Chapter for the “anti-CD19 + Lenalidomide” Combination in Previously Untreated DLBCL
  • 100% Objective Response Rate! AMC-095 Study Confirms the Efficacy and Safety of Ibrutinib Integrated into R-da-EPOCH for HIV-Associated DLBCL
Recent Comments
    Archives
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top